NewslettersCell Therapy NewsHematopoiesis NewsHuman Immunology News Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies By Danielle Corrigan - August 3, 2022 0 Poseida Therapeutics, Inc. announced it has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. [Poseida Therapeutics, Inc.] Press Release